{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-341385","form_type":"8-K","ticker":"FULC","cik":"0001680581","company_name":"Fulcrum Therapeutics, Inc.","filed_at":"2026-08-10T12:43:36+00:00","discovered_at":"2026-08-10T12:45:00.331061+00:00","generated_at":"2026-08-10T12:45:06.118767+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Fulcrum CFO Musso takes on principal accounting officer role as Tourangeau departs","bullets":["Greg Tourangeau, VP Finance and principal accounting officer, departs Fulcrum effective August 7, 2026.","CFO Alan Musso appointed principal accounting officer effective August 7, 2026, succeeding Tourangeau.","Musso receives no additional compensation for the added principal accounting officer duties.","No family relationships or material interests involving Musso were disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-341385","json":"https://secwatch.observer/filing/0001193125-26-341385.json","markdown":"https://secwatch.observer/filing/0001193125-26-341385.md","text":"https://secwatch.observer/filing/0001193125-26-341385.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1680581/000119312526341385/0001193125-26-341385-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1680581/000119312526341385/fulc-20260807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-10T12:45:06.118767+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}